Eventi Capital Partners
Eventi Capital Partners
Type of Funding
Venture Capital
Max Funding
N/A
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Health and other services.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Eventi Capital Partners (ECP) is a Toronto-based growth capital investment group, specializing in software-as-a-service, Internet infrastructure services and more recently medical devices.
Founded in 2002, Eventi Capital Partners leverages the extensive operational and investment experience of its Managing Partners to enable CEOs to scale their business more predictably.
They invest in passionate entrepreneurs who possess deep domain expertise and are committed to building a scalable company that delivers exceptional value to its customers.
Eligibility
Early stage companies
Similar funding programs
Venture Capital
Front Row Ventures is the first Canadian venture capital fund entirely managed by and for students that invests solely in student-led startups.
Powered by Real Ventures, FRV has successfully run a $600K Quebec-focused pilot fund over the past two years and is now raising a $10M fund to expand its operations to 7 new provinces and more than 30 university campuses across Canada.
Max Funding $25,000.00
Front Row Ventures
Venture Capital
Version One Ventures (formerly W Media Ventures) is an early-stage fund investing in outstanding consumer internet, SaaS, and mobile entrepreneurs throughout North-America.
The firm was founded in 2012 and is based in Vancouver, Canada.
Max Funding N/A
Version One
Venture Capital
Based in Montréal, CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S.
CTI Life Sciences currently manage $245 million of assets.
Max Funding N/A
CTI Life Sciences